Shree Ganesh Biotech India Ltd Share Price Today - Shree Ganesh Biotech India Ltd Stock Price Live NSE/BSE

Shree Ganesh Biotech India Ltd

NSE: BSE: 539470

₹0.59

(9.26%)

Thu, 02 Apr 2026, 00:29 pm

MTF 5xInvest in Shree Ganesh Biotech India Ltd with 5x Leverage Buy with MTF

Market Cap215.26M

PE Ratio0

Dividend0

Process Industries

Agricultural Commodities/Milling

24.5K

Shree Ganesh Biotech India Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
23.12
Net Profit
0.28
P/B
0.57
Sector P/E
39.23
P/E
90
EV/EBITDA
91.97
Debt/Equity (Industry)
0.29
Interest Cover (Industry)
4.34
ROCE (Industry)
9.10
RONW (Industry)
6.98
ROE
0.44
ROCE
0.62
Debt/Equity
0
EPS (TTM)
0
Dividend Yield
0
Book Value
1.60
Interest Cover
0

Analysis

all

Pros

Shree Ganesh Bio-Tech (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Shree Ganesh Bio-Tech (India) is profitable, therefore cash runway is not a concern.
Shree Ganesh Bio-Tech (India) is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 110.3x debt.
Shree Ganesh Bio-Tech (India)'s cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Shree Ganesh Bio-Tech (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Shree Ganesh Bio-Tech (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
The average tenure for the Shree Ganesh Bio-Tech (India) board of directors is less than 3 years, this suggests a new board.
Shree Ganesh Bio-Tech (India) is not covered by any analysts.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	0	0	0	0	0
FII	1.42	1.42	1.42	1.42	1.42
DII	0	0	0	0	0
Public	98.58	98.58	98.58	98.58	98.58
Government	0	0	0	0	0

Technical Analysis

RSI

53.60

MACD

-0.01

50 DMA

0.61

200 DMA

0.71

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	0.77	0.67	0.61	0.57	0.51	0.47	0.37
Fibonacci	0.67	0.64	0.61	0.57	0.54	0.51	0.47
Camarilla	0.57	0.56	0.55	0.57	0.53	0.52	0.51

Pivots Level: Classic

+0.20

0.77

+0.10

0.67

+0.03

0.61

0.57

Pivot Point

LTP: 0.60

-0.07

0.51

-0.10

0.47

-0.20

0.37

Moving Average

SMAEMA

Period

Value

10-EMA
0.57
20-EMA
0.58
30-EMA
0.59
50-EMA
0.61
100-EMA
0.64
200-EMA
0.71

Announcement Date	Purpose	Action	Ex Date
29 Jan 2026	board-meetings	Quarterly Results
08 Nov 2025	board-meetings	Quarterly Results
25 Aug 2025	agm
13 Sept 2024	agm
01 Sept 2023	agm
13 Sept 2022	agm
28 Mar 2022	bonus	Bonus issue 1:1	28 Apr 2022
14 Mar 2022	bonus	1:1 Bonus Issue of Equity Shares	28 Apr 2022
11 Jan 2022	split	Stock Split From Rs.10 to Rs.1	11 Feb 2022
20 Dec 2021	split	1:10 Splits of Equity Shares	11 Feb 2022

Shree Ganesh Biotech India Ltd

Lupin Ltd

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Shree Ganesh Biotech India Ltd About

Shree Ganesh Biotech India is primarily engaged in the production, processing, and marketing of high-quality hybrid seeds for crops like corn, sunflower, cotton, and paddy, as well as seeds and bhushi.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1982

Headquarters

CEO

Aman Patel

Employees

Contact

Website

http://www.shreeganeshbiotech.com

shreeganeshbiotechindialtd@gmail.com

Phone

Location

6 Flr Premises-602 Mahavir Apt, 2 Aushutosh Mukherjee Road, Kolkata, West Bengal, 700020

Year	History
1982	The company SHREE GANESH BIOTECH (INDIA) LIMITED was incorporated.
2015	Shree Ganesh Bio-Tech listed its equity shares.
2022	The Company has issued Bonus Shares in the Ratio of 1:1.

Client Name	Order Side	QTY	Avg Price	Date
NEW ERA FUND LIMITED	Sell	3000000	1.1	27 Mar 2024
TOPGAIN FINANCE PRIVATE LIMITED	Buy	500000	1.47	08 Jan 2024
TOPGAIN FINANCE PRIVATE LIMITED	Sell	2958016	1.47	08 Jan 2024
TOPGAIN FINANCE PRIVATE LIMITED	Sell	8637984	1.56	05 Jan 2024
SETU SECURITIES PVT. LTD.	Buy	2568661	1.48	04 Jan 2024
TOPGAIN FINANCE PRIVATE LIMITED	Buy	11596000	1.49	04 Jan 2024
SHRI CHAND	Sell	3012000	1.48	04 Jan 2024
ASHOK KUMAR	Buy	4410000	1.33	20 Dec 2023
NATTAYA CHOWDHURY	Sell	6000000	1.11	14 Dec 2023
SHRI CHAND	Buy	2660000	1.14	14 Dec 2023

Shree Ganesh Biotech India Ltd News

Shree Ganesh Bio-Tech Q3FY26 Results Announced

Shree Ganesh Bio-Tech (India) Limited reported Q3FY26 results with revenue of ₹69.81 lakh and net profit of ₹32.23 lakh for quarter ended December 31, 2025.

29 Jan 2026

co actions results

Shree Ganesh Bio-Tech Reports Quarterly Financial Results for September 2025

Shree Ganesh Bio-Tech (India) Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported revenue from operations of Rs 231.38 lakhs for the quarter compared to Rs 198.40 lakhs in the previous quarter. For the half year, revenue reached Rs 551.01 lakhs versus Rs 229.76 lakhs in the prior period. The company recorded a profit before tax of Rs 34.11 lakhs for the half year compared to Rs 56.12 lakhs in the previous year. The board meeting was held on November 8, 2025, where directors approved the financial results. The company operates in a single business segment and has undergone a limited review by statutory auditors.

08 Nov 2025

earnings

Shree Ganesh Biotech Reports 37.5% Jump in Net Profit for Quarter Ended June 2025

Shree Ganesh Biotech (India) Limited reported net profit of Rs. 32.70 lacs for the quarter ended June 30, 2025, compared to Rs. 23.78 lacs in the same quarter of the previous year. The company's revenue from operations declined to Rs. 138.36 lacs from Rs. 355.61 lacs year-on-year. Total income decreased to Rs. 179.89 lacs from Rs. 392.47 lacs in the corresponding quarter. Total expenses fell to Rs. 147.19 lacs from Rs. 368.69 lacs. The company's earnings per share remained at Rs. 0.01 for both basic and diluted calculations. The Board of Directors approved these unaudited financial results in a meeting held on July 25, 2025.

25 Jul 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800